KORU Medical (KRMD): חובות להיוון בספרים

This daily price chart for KORU Medical Systems (KRMD) reflects figures at 0.18. KORU Medical Systems is implementing sustainable development principles by minimizing plastic use in packaging and optimizing resources during the production of infusion systems. The business dominates the home subcutaneous drug delivery device segment, protecting profits through strict licensing requirements. Growth is driven by partnerships with pharmacy chains and biologic drug developers.

When selecting defensive assets, the stability of the capital structure and the minimization of debt load become key criteria. For KORU Medical Systems (KRMD), whose stability is based on the expansion of the home treatment segment for chronic patients in the US, analyzing the company's debt-to-book capitalization allows for daily monitoring of the balance between debt obligations and equity, assessing leverage risk between quarterly reports.